Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Schellong

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
The American Journal of Medicine|March 19, 2013
Low-molecular-weight or unfractionated heparin in venous thromboembolism: the influence of renal functionJavier Trujillo-Santos, Sebastian Schellong, Conxita Falga, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 4, 2021
Incidence and severity of postthrombotic syndrome after iliofemoral thrombosis - results of the Iliaca-PTS - RegistryJamil Nawasrah, Barbara Zydek, Jessica Lucks, et al.
Thrombosis and Haemostasis|July 15, 2016
Treatment of acute pulmonary embolism with dabigatran versus warfarin. A pooled analysis of data from RE-COVER and RE-COVER IISamuel Z Goldhaber, Sebastian Schellong, Ajay Kakkar, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 20, 2016
Post-thrombotic syndrome 3 years after deep venous thrombosis in the Thrombosis and Pulmonary Embolism in Out-Patients (TULIPA) PLUS RegistryViola Hach-Wunderle, Rupert Bauersachs, Horst-Eberhard Gerlach, et al.
Clinical Cardiology|December 3, 2003
Practicability and limitations of enhanced external counterpulsation as an additional treatment for anginaDierk Werner, Joachim Kropp, Sebastian Schellong, et al.
Thrombosis and Haemostasis|December 5, 2017
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER IISamuel Z Goldhaber, Sam Schulman, Henry Eriksson, et al.
Vascular Medicine (London, England)|November 4, 2016
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™Samuel Z Goldhaber, Henry Eriksson, Ajay Kakkar, et al.
The New England Journal of Medicine|December 8, 2009
Dabigatran versus warfarin in the treatment of acute venous thromboembolismSam Schulman, Clive Kearon, Ajay K Kakkar, et al.
Angiology|March 24, 2022
Safety and Effectiveness of Endovascular Therapy for the Treatment of Peripheral Artery Disease in Patients with and without Diabetes MellitusGrigorios Korosoglou, Sorin Giusca, Ralf Langhoff, et al.
Thrombosis and Haemostasis|March 6, 2015
Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancerSam Schulman, Samuel Z Goldhaber, Clive Kearon, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
The American Journal of Medicine|March 19, 2013
Low-molecular-weight or unfractionated heparin in venous thromboembolism: the influence of renal functionJavier Trujillo-Santos, Sebastian Schellong, Conxita Falga, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 4, 2021
Incidence and severity of postthrombotic syndrome after iliofemoral thrombosis - results of the Iliaca-PTS - RegistryJamil Nawasrah, Barbara Zydek, Jessica Lucks, et al.
Thrombosis and Haemostasis|July 15, 2016
Treatment of acute pulmonary embolism with dabigatran versus warfarin. A pooled analysis of data from RE-COVER and RE-COVER IISamuel Z Goldhaber, Sebastian Schellong, Ajay Kakkar, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 20, 2016
Post-thrombotic syndrome 3 years after deep venous thrombosis in the Thrombosis and Pulmonary Embolism in Out-Patients (TULIPA) PLUS RegistryViola Hach-Wunderle, Rupert Bauersachs, Horst-Eberhard Gerlach, et al.
Clinical Cardiology|December 3, 2003
Practicability and limitations of enhanced external counterpulsation as an additional treatment for anginaDierk Werner, Joachim Kropp, Sebastian Schellong, et al.
Thrombosis and Haemostasis|December 5, 2017
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER IISamuel Z Goldhaber, Sam Schulman, Henry Eriksson, et al.
Vascular Medicine (London, England)|November 4, 2016
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™Samuel Z Goldhaber, Henry Eriksson, Ajay Kakkar, et al.
The New England Journal of Medicine|December 8, 2009
Dabigatran versus warfarin in the treatment of acute venous thromboembolismSam Schulman, Clive Kearon, Ajay K Kakkar, et al.
Angiology|March 24, 2022
Safety and Effectiveness of Endovascular Therapy for the Treatment of Peripheral Artery Disease in Patients with and without Diabetes MellitusGrigorios Korosoglou, Sorin Giusca, Ralf Langhoff, et al.
Thrombosis and Haemostasis|March 6, 2015
Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancerSam Schulman, Samuel Z Goldhaber, Clive Kearon, et al.
Pageof 12